Log in to save to my catalogue

Soluble urokinase plasminogen activator receptor, platelet aggregation, and carotid plaque thickness...

Soluble urokinase plasminogen activator receptor, platelet aggregation, and carotid plaque thickness...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2896811673

Soluble urokinase plasminogen activator receptor, platelet aggregation, and carotid plaque thickness in diabetes: A cross-sectional analysis

About this item

Full title

Soluble urokinase plasminogen activator receptor, platelet aggregation, and carotid plaque thickness in diabetes: A cross-sectional analysis

Publisher

United States: Elsevier Limited

Journal title

Journal of diabetes and its complications, 2024-01, Vol.38 (1), p.108654-108654, Article 108654

Language

English

Formats

Publication information

Publisher

United States: Elsevier Limited

More information

Scope and Contents

Contents

BackgroundSoluble urokinase plasminogen activator receptor (suPAR) is an inflammatory biomarker strongly linked with cardiovascular disease in diabetes. By investigating its association with platelet aggregation levels and carotid plaque thickness, we can potentially improve the characterization of cardiovascular pathophysiology in type 1 (T1D) and...

Alternative Titles

Full title

Soluble urokinase plasminogen activator receptor, platelet aggregation, and carotid plaque thickness in diabetes: A cross-sectional analysis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2896811673

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2896811673

Other Identifiers

ISSN

1056-8727

E-ISSN

1873-460X

DOI

10.1016/j.jdiacomp.2023.108654

How to access this item